(Total Views: 538)
Posted On: 09/30/2025 1:00:02 AM
Post# of 157632
Quote:
∼18% of patients with mTNBC treated with leronlimab in combination, or subsequently, with (ICI are currently alive (median >60 months).
Quote:
I believe it should read "∼18% of patients with mTNBC treated with leronlimab are currently alive (median >60 months)."
Your statement would be correct since all patients were treated with leronlimab. The AACR statement is also correct and mentioned ICIs to make the point that it was the combination of leronlimab and PD-L1 inhibitors that actually achieved it.
(7)
(0)
